Search results
Results From The WOW.Com Content Network
Andrew David Huberman (born September 26, 1975) is an American neuroscientist and podcaster. He is an associate professor of neurobiology and ophthalmology at the Stanford University School of Medicine. Since 2021, he has hosted the popular health and science focused Huberman Lab podcast. The podcast has attracted criticism for promoting poorly ...
Another added: “This article shows Andrew Huberman to be a huge dirtbag and very dishonorable in his treatment of women, although its description of his management of a five-simultaneous ...
A dopamine reuptake inhibitor (DRI) is a class of drug which acts as a reuptake inhibitor of the monoamine neurotransmitter dopamine by blocking the action of the dopamine transporter (DAT). Reuptake inhibition is achieved when extracellular dopamine not absorbed by the postsynaptic neuron is blocked from re-entering the presynaptic neuron.
Tuberoinfundibular pathway shown in opaque blue, connecting that hypothalamus with the pituitary gland. The tuberoinfundibular pathway refers to a population of dopamine neurons that project from the arcuate nucleus (a.k.a. the "infundibular nucleus") in the tuberal region of the hypothalamus to the median eminence. [1]
Huberman cites Carol Dweck, a psychologist at Stanford University and author of Mindset: How You Can Fulfill Your Potential, whose 1998 research set the stage for how effort-based praise over ...
Dopamine dysregulation syndrome (DDS) is a dysfunction of the reward system observed in some individuals taking dopaminergic medications for an extended length of time. It is characterized by severely disinhibited patterns of behavior, [1] leading to problems such as addiction to the offending medication, gambling addiction, or compulsive sexual behavior, [2] along with a general orientation ...
Dopamine beta (β)-hydroxylase deficiency is a human medical condition involving inadequate dopamine beta-hydroxylase. It is characterized by increased amounts of serum dopamine and the absence of norepinephrine (NE) and epinephrine. Dopamine is released, as a false neurotransmitter, in place of norepinephrine (aka noradrenaline and ...
The mesolimbic pathway and its positioning in relation to the other dopaminergic pathways. The mesolimbic pathway is a collection of dopaminergic (i.e., dopamine-releasing) neurons that project from the ventral tegmental area (VTA) to the ventral striatum, which includes the nucleus accumbens (NAcc) and olfactory tubercle. [9]